SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001047469-18-000284
Filing Date
2018-01-19
Accepted
2018-01-19 17:14:25
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 a2234288zs-3.htm S-3 154408
2 EX-4.4 a2234288zex-4_4.htm EX-4.4 173348
3 EX-5.1 a2234288zex-5_1.htm EX-5.1 15437
4 EX-23.1 a2234288zex-23_1.htm EX-23.1 3116
5 G33281KQI001.GIF g33281kqi001.gif GRAPHIC 2031
6 G33281KQI002.GIF g33281kqi002.gif GRAPHIC 4566
7 G622400.JPG g622400.jpg GRAPHIC 30586
  Complete submission text file 0001047469-18-000284.txt   399043
Mailing Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-222634 | Film No.: 18538111
SIC: 2834 Pharmaceutical Preparations